Prostate Cancer | Meet The Professor: Optimizing the Management of Metastatic Castration-Resistant Prostate Cancer — Part 2

Featuring perspectives from Dr A Oliver Sartor, including the following topics: Introduction (0:00) Case: A man in his mid-70s with metastatic castration-resistant prostate cancer (mCRPC) — Nataliya Mar, MD (3:03) Case: A man in his early 80s with mCRPC with loss of heterozygosity and an AR-V7 splice site mutation — Spencer Henick Bachow, MD (14:21) Case: A man in his mid-70s with mCRPC enrolled in the VISION trial — Sulfi Ibrahim, MD (17:44) Case: A man in his late 60s with metastatic hormone-sensitive prostate cancer and an ARID1A mutation — Syed F Zafar, MD (37:49) Case: A man in his early 60s with mCRPC, a somatic BRCA1 mutation and high tumor mutational burden — Dr Bachow (46:52) Case: A man in his early 70s with mCRPC and a germline RAD51c mutation — David S Morris, MD (53:57) CME information and select publications